Previous in vitro studies by our group have shown that astemizole, a non-selective EAG1 blocker, synergized with calcitriol to inhibit breast cancer cell proliferation by modifying EAG1 gene expression and possibly its activity as well[17]. The gene discussed is KCNH1; the disease is breast carcinoma.